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Abstract. The growth of human cancers is characterised by long and variable cell cycle times that are controlled by 
stochastic events prior to DNA replication and cell division. Treatment with radiotherapy or chemotherapy induces a 
complex chain of events involving reversible cell cycle arrest and cell death. In this paper we have developed a math-
ematical model that has the potential to describe the growth of human tumour cells and their responses to therapy. We 
have used the model to predict the response of cells to mitotic arrest, and have compared the results to experimen-
tal data using a human melanoma cell line exposed to the anticancer drug paclitaxel. Cells were analysed for DNA 
content at multiple time points by flow cytometry. An excellent correspondence was obtained between predicted and 
experimental data. We discuss possible extensions to the model to describe the behaviour of cell populations in vivo. 
1. Introduction 
The mammalian cell division cycle forms one of the cornerstones of our current un-
derstanding of tumour growth in humans and is dominated by four phases, G1 -phase, 
S-phase, G2-phase and M-phase, with DNA replication occurring in S-phase and mito-
sis and cell division occurring in M-phase. The transitions from G1-phase to S-phase, 
and from G2-phase to M-phase, are controlled by all-or-nothing transitions involving a 
positive feedback system of cyclin-dependent kinases, cyclins and phosphatases ([16]). 
These transitions are the likely cause of the highly variable length of the cell cycle, most 
of which is accounted for by variability in G1 -phase duration ([22)). Early studies on 
cell cycle dynamics in cultured cells suggested the existence of a 'transition probability' 
regulating the commitment of G1 -phase cells to S-phase in order to account for this vari-
ability ([28]). In human cancers, the median cycle time also differs for individual cancer 
patients. The range of median cell cycle times varies from two days to several weeks 
with a median of approximately 6 days ([37]). Since the durations of S-phase, G2-phase 
and M-phase are relatively short, most of the cancer cells in a patient's tumour are in 
G1 -phase. Human cancer is characterised by a high rate of tumour cell turnover, such that 
the rate of cell death is up to 95% of the rate of cell division ([36]). Cell death may occur 
by two main processes, programmed death (apoptosis), which is likely to be the most 
common cause of cell turnover within a tumour, and necrosis, which is generally caused 
by localised failure of the tumour's blood supply. 
Many mathematical models describing the behaviour of cell populations have been 
developed over the last half century, including models differentiated by size ([5, 27]). 
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Variations of these models have been subject to rigorous mathematical analysis, espe-
cially in terms of the existence and stability of the steady size distribution that they may 
exhibit under certain conditions (see [8, 9, 15, 31, 12, 25]). Cell size models have been re-
viewed by [2]. Other studies on cell cycle control have used an age structured approach 
([26,32,23, 19]) or modelled molecular events ([6]). 
In this paper we have explored an alternative approach to the analysis of human cell 
cycle dynamics. We have used DNA content as a measure of the generic term 'cell size' 
in the model because the transitions from G1-phase to S-phase and from M-phase to cell 
division are accompanied by changes in DNA content, which can be measured in a tu-
mour population by flow cytometry. We have also included terms that have the potential 
to describe cell loss from a population. Since DNA content is measured in individual cells 
as they traverse a laser beam and inhomogeneity of illumination leads to a Poisson dis-
tribution of values, we have included a term to reflect the methodological aspects of flow 
cytometry. The mathematical model therefore provides a visual output that can be com-
pared directly with experimental findings. As an initial step in the mathematical analysis 
of cell cycle perturbation, we have examined the effect of inhibition of cell division on 
the cell cycle distribution of a human melanoma cell line (NZM6). We have exposed this 
line to the drug paclitaxel, a clinically important anticancer drug that prevents cell divi-
sion by arresting cells in mitosis ([24]), and have compared experimental data obtained 
using flow cytometry to the predicted values of the model. 
2. Mathematical Model 
For the mathematical model we chose four compartments representing the sub-populations 
of cells, G1, S, G2, and M, distinguished by their position within the cell cycle (Figure 
1). The transition from G2-phase to M-phase cannot easily be measured by flow cytom-
etry, but we consider that it is an important part of the model. The dependent variables, 
G1 (x,t), S(x, t), G2(x, t) andM(x, t), can each be thought of as the number density of cells 
with relative DNA content x at time t. Directly after cell division, a newly divided daugh-
ter cell with relative DNA content scaled to x = 1, will double its DNA content during 
S-phase, so that at mitosis this model of the cell has relative DNA content approximately 
x=2. 
The movement between the four compartments is represented by the schematic dia-
gram in Figure 1 which expresses the accumulation in each compartment and the move-
ment between them. Our model equations are: 
aG1 2 Tt(x,t) = 2 bM(2x,t)-(k1 +µ0 1)G1(x,t), (1) 
as a2s as 
ai(x,t) = D ax2 - µsS(x,t)- g ax (x,t) +k1 G1 (x,t)-I(x,t;Ts), (2) 
aG2 
-a (x,t)=I(x,t;Ts)-(k2+µ0 2 )G2(x,t), (3) t ' 
aM 
at (x,t) = k2G2(x,t)-bM(x,t)-µMM(x,t), (4) 
where the domain of definition is: 0 < x < oo, and t > 0. The time variable, t, is measured 
in hours while x, relative DNA content, is dimensionless. All parameters in the model 
may be functions of either t or x or both. 
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In equation (1), describing G1-phase, the first term on the right-hand-side is the source 
term provided by the influx of newly divided daughter cells from M-phase. A cell in M-
phase divides into two identical daughter cells at a rate of b divisions per unit time. The 
22 part of this term arises from the fact that, at division, all cells with DNA content in 
the interval [2x, 2x + 2.6.x] are doubled in number and mapped to an interval with half 
the DNA content, namely [x,x+ .6.x]. Thorough derivations of similar non-local terms 
can be found in both [9] and [31]. The second term in equation (1) describes the loss 
of cells from G1 -phase due to either death (the µa 1 G1 (x, t) term) or transition to the S-
phase (k1 G1 (x, t) ). Therefore k1 provides the stochastic transition from the G1 -phase to 
S-phase and represents the probability per unit time per unit cell that the cell will enter 
the S-phase. 
In equation (2), describing S-phase, g is the average rate at which the relative DNA 
content of a cell increases with time. For a homogeneous tumour cell population, cells in 
G1-phase and G2 and M-phase, will each have constant DNA contents. However, in flow 
cytometry the cells are not all illuminated evenly as they pass through the flow cytometer 
and this causes an apparent variation of DNA content. The dispersion term, Df}:, can be 
used to account for this variability. The inclusion of this parameter in the model allows us 
to compare model output DNA profiles directly with those obtained experimentally. Cells 
die in S-phase, equation (2), at a per capita rate of µs per unit time. The term I(x, t; Ts), 
given by equation (10) and discussed in section 2.1, represents the sub-population of 
cells which entered S-phase Ts hours previously and are ready to exit from S-phase to 
G2-phase. 
The loss term, I(x, t; Ts), becomes the corresponding source term in the equation (3) 
representing G2-phase. The second term in equation (3) accounts for the loss due to either 
exit to M-phase or cell death. Thus µa2 is the per capita death rate of cells in G2-phase 
while k2 is the transition rate of cells from G2-phase to M-phase. 
Finally in equation (4), we have cells dividing at a rate of b divisions per unit time. 
Cells die at the per capita rate of µM per unit time and k2G2(x,t) is the source term from 
G2-phase. A summary of the model parameter descriptions and units is given in Table 1. 
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As it stands the model is incomplete as no side (initial or boundary) conditions have 
been specified for the equations (1)-(4); we rectify this now. In accordance with experi-
mental evidence, we choose the following side data for these equations: 
G1(x,O) = Aexp( 
2n8J 
G2(x,O) =0, 
as 
D a)O,t)-gS(O,t) = 0, t > 0. 
(x-1)2 ) 
2e2 ' 0 
S(x,O) = 0, 0 <x < oo, 
M(x,O) =0, 0 <x < oo, 
The equation D~;(O,t)- gS(O,t) = 0 is a zero flux boundary condition. We choose the 
DNA content of cells in G1 -phase at time t = 0 to be a Gaussian distribution with relative 
mean DNA content at x = 1 and variance eJ. We choose e0 to be sufficiently small so 
that the extension of G1 (x, 0) into the infeasible region x < 0 is of no significance and 
we consider x > 0 only. The variance, eo, here reflects not only inter-cell heterogeneity 
of DNA content but also the observed DNA distribution (Poisson) seen in G 1-phase flow 
cytometry profiles which is a consequence of experimental error and the fact that cells 
are not illuminated evenly during flow cytometry. The total number of cells at time zero 
is 
100 ao [ 1 ] G1(x,O)dx=- l+erf( 1'1F) . o 2 v2eo 
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Fig. 2. The evolution of a distribution of cells, k1 G(x,t), that enter S-phase from the G1 -phase at time 't' = 0 hours. 
The incremental time step is 1 hour. The cell distribution labelled 't' =Ts= 10 hours is about to be injected into the 
G2-phase. The parameters are D = O.ol, g = 0.1, k1 = 0.1, µs = 0, and G1 (x,t) = G1 (x,O) = . ~exp(-<x2--;,~
2
) 
y2trB0 uo 
where ao = l 00, Bo = 0.1. For parameter descriptions and units see Table 1. 
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2.1. Examination of the cell transition from the S-phase 
During S-phase (see equation (2)), the relative DNA content of a cell increases at an 
average rate g per unit time. The cells are modelled to leave the S-phase for the G2-phase 
after a fixed time Ts hours. We now obtain an expression for this loss term, l(x,t; i- = Ts), 
of cells from S-phase to G2-phase. 
We denote the group of cells, entering S-phase at time t as l(x,t; i- = 0) =lo(x,t). The 
model assumes that this group of cells simply enter S-phase, double their DNA content 
( or die) and then exit to the next phase ( G2) without any interaction with cells that enter 
S-phase at different times. While in S-phase the DNA profile of the original cell cluster 
evolves dynamically as depicted in Figure 2. Thus, for a particular time t, the transition 
of the group of cells into S-phase occurs as an initial condition and the dynamics of any 
one particular cell group, while in S-phase, are governed by the homogeneous initial-
boundary value problem: 
di di d21 
d't"(x,t;i-)+gdx-Ddx2 +µsl=O, O<x<oo, t>i->0, (5) 
with side conditions 
l(x,t; i- = 0) = lo(x,t), 0 <x < oo, t 2: 0, di D d)O,t)-gl(O,t) = 0, t 2: i- 2: 0. 
(6) 
Equation (5) is simply equation (2) with the source term, k1G1(x,t), and the loss term, 
l(x, t; Ts), omitted. 
By Laplace transformation techniques (([20), pp. 173), ([10), pp. 207 et. seq.)), and 
the observation that the solution to the partial differential equation is translation invariant 
in the time variable, the solution to this associated equation is 
I( ) { 
{°° lo(y,t)y(i-,x,y)dy, 
x,t;i- = lo 
lo(x,t), 
i-,x,y> 0, (7) 
i-=0, 
where 
y(i-,x,y) = 2~ ( e-((x-g-r:)-y)z/4D-r: - (1 + v( i-,x,y))e-((x+g-r:)+y)2/4D-r:)' i-,x,y > 0 
(8) 
with 
v(i-,x,y) = (x+y) (l+o'(i--1)). 
g'L" 
Here yis the Green's function for the partial differential operator in equation (5). It is seen 
that the formula for y is valid for large time and this result follows from the Tauberian 
theorem for the Laplace transformation. 
We now define 
where 
-µs-r: y- e e-((x-g-r:)-y)2 /4D-r: 
- 2V7iin ' 
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it then follows that I = I - [z where 
h(x,t; r) = fo 00 Io(y,t)y( r,x,y)(l + v( r,x,y))e-x(y+g1:)/2D1: dy. (9) 
The kernel y is the fundamental solution for the partial differential equation (5) when 
x E (-00,00); i.e. when the second term in the parenthesis of equation (8) is not present. 
This second term is the image term and it ensures that the no-flux boundary condition is 
satisfied. For numerical evaluation of the I integral in our problem it is only necessary to 
use I as we show in the Appendix; this simplifies the analytical solution of equation (5) 
and is an acceptable approximation if the dispersion is small and Io(x, t) is zero for small 
x. 
At time t, the k1 G(x, t - Ts) cells which entered S-phase Ts hours previously, are due 
to exit S-phase and enter G2-phase. The loss term I(x, t; Ts) in equation (2) provides for 
this, and is obtained from equation (7) with the substitutions Io(x,t) = k1 G(x,t-Ts) and 
r = Ts, giving 
( ) { r k1G1(y,t-Ts)y(Ts,x,y)dy, t ~ Ts, I x,t,Ts = lo O t < Ts. (10) 
We observe that the transition term from the G1 -phase acts as a source term for the 
S-phase and note that both time variables, t and r, evolve at the same rate. Hence, by 
using Duhamel's principle ([17), pp. 70), we find that the number of cells in S-phase, and 
the solution of equation (2), is 
!otl loco S(x,t) =k1G(x,t)+ k1G1(y,t-r)y(r,x,y)dydr, o+ o { Ts, t ~ Ts, ti= t, t<Ts. (11) 
The distribution of cells in S-phase at a particular time t can be interpreted as an infinite 
sum of DNA profiles as depicted in Figure 2. 
2.2. No dispersion in S-phase: 
By setting D = 0 in equation (2), we obtain the case of no dispersion. Our side condi-
tions remain unchanged except the boundary condition on x = 0, S(O,t), becomes the 
homogeneous Dirichlet condition. We again denote the transition of a group of cells from 
G1-phase into S-phase as an initial condition, I(x, t; r = 0) = Io(x, t), where I(x,t; r) sat-
isfies the equation 
c)[ c)[ 
d'r (x, t; -r) + g dX +µ,sf= 0, 0 < X < oo, t > r > 0, 
with side conditions 
This gives 
I(x,t; r = 0) = Io(x,t), 0 < x < oo, t ~ 0. 
{
Io(x- gr,t- r)e-µsr, 
I(x t·r) = 
' ' o, 
(12) 
(13) 
(14) 
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The term I(x, t; Ts) in equation (2), for the case of no dispersion (D = 0), is then given by 
setting Io(x, t) = k1 G1 (x, t-Ts) and -r = Ts in equation (14): 
. -{e-µsTsk1G1(x-gTs,t-Ts), x>gTs, t~Ts, 
I(x,t,Ts)- 0, \:/ x>O, t<Ts, 
0, x S: gTs, \:/ t > 0. 
Similarly the solution of equation (2) when D = 0 is 
t1 = 
2.3. Steady DNA Distributions (SDD's) and model parameter values 
{
Ts, 
t, 
t ~ Ts, 
t < Ts. 
(15) 
(16) 
In single functional equations and functional systems ((25]), it has been found that the 
dependent variables, in our case G1 (x,t), S(x, t), G2(x, t) andM(x, t), either grow or decay 
exponentially with time but their distribution in the x-variable is in steady state ((11-14, 
35)). These are the type of distributions that we term steady DNA distributions (SDD's). 
The term asynchronous cell growth is also applied in the literature to describe SDD's 
([l],[25],[23]). It has been shown ([25]) that this steady state in the x-variable is both 
uniquely determined by model parameters and is independent of the initial distribution at 
time t = 0. 
SDD's are found experimentally via DNA profiles or histograms from flow cytometry 
and we simulate this type of temporal experimental data using our model ( equations 
(1)-(4)). In an experiment we typically have a cell line with a steady DNA distribution. 
This cell line is then perturbed by either radiation or the addition of anticancer drugs. To 
model the resultant cell kinetics of the experiment we estimate a set of parameters for 
the model and then find the corresponding steady DNA distribution. The perturbed cell 
line is then modelled by altering model parameters. The main considerations are: How do 
we estimate the model parameters and which parameters should be altered to mimic the 
perturbed cell line kinetics. For the remainder of this subsection we discuss previously 
published results from a number of authors that help us gain preliminary estimates of 
model parameters for a cell population with a steady DNA distribution. 
When a cell population has a steady DNA profile, the underlying system of equations 
are ordinary differential equations ((8)). Using this and the age structured modelling ap-
proach ((29, 33, 34)), it is possible to obtain estimates of model parameters of a cell pop-
ulation which has a steady DNA distribution. Equations (17) - (20) below give Steel's 
formulas ((29, 33)), for the average time spent in each phase as a function of the percent-
age of cells in each phase and the doubling time of the cell line. 
Tc= Td, 
log ( %S~~OG2M + 1) 
Ts= Tc log2 -Ta2M, 
log (¥o+ 1) 
Ta2M = Tc log2 ' 
Ta1 = Tc - Ta2M - Ts, 
(17) 
(18) 
(19) 
(20) 
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Here Ta1, Ts and Ta2M are the average times spent in G1, S, and G2M phase respectively. 
Tc is the cell cycle time and Td is the doubling time of the cell population. %G1, %S and 
%G2M are the percentage of cells in G1 -phase, S-phase and G2M-phase respectively. For 
a population of cells with a steady DNA distribution, the values of these percentages are 
unchanging in time. 
We use the theory described by [30] which says that, for an SDD, the average time in 
each phase is related to the model parameters by the following equations: 
1 
Ta1 = , 
k1 ++µa1 
1 
Ts=--, 
g+µs 
1 
Ta2 = ' k2 +µa2 
1 
TM= b+µM· 
The rate of convergence, R, to the SDD has been estimated by [7] as: 
R = 2:2 ( C:n) 2 , 
(21) 
(22) 
(23) 
(24) 
(25) 
where m is the mean duration of the cell cycle and CVm is the variation of the mean 
duration of the cell cycle. If we use m = Tc = Ta, +Ts+ T a2 +TM, we observe that if any 
of the denominators in equations (21)-(24) are close to zero, the length of time in that 
particular phase will tend towards infinity and the rate of convergence to the SDD will 
tend towards zero. 
3. Results 
3.1. Flow cytometric studies 
A human melanoma line (NZM6) was grown to a logarithmic phase of cell growth (ex-
ponential growth) using conditions that have been described previously ([18]). A mitotic 
inhibitor (paclitaxel) was then added at a concentration (200 nM) sufficient to inhibit cell 
division, and samples were removed for cell analysis at various times later. Flow cytome-
try was carried out by standard methods as described previously ([21]). A DNA standard 
( chicken red blood cells) was added to some of the samples to calibrate the cytometer. 
3.2. Model Results for NZM6 
We used the model to mimic the cell kinetics of the human melanoma cell line NZM6 
when the anticancer drug paclitaxel was added to this cell population at time t = 0. Prior 
to the addition of this drug, the cell line has a steady DNA distribution. We show that 
it is appropriate to use constant model parameter values to depict the dynamics of cell 
numbers as a function of DNA content and time. Since this cell line has minimal ability 
in steady state to undergo apoptosis, we denote the death rate parameters, µa1, µs, µa2, 
and µM, as zero. 
For NZM6, the percentage of cells in each phase for cells with a steady DNA dis-
tribution was estimated by flow cytometric analysis as %G1 = 63.66, %S = 25.8 and 
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Fig. 3. Percentage of cells in each phase as a function of time. Model and Data for human cell line NZM6. Division 
stopped at t = 0 hours. The DNA profiles at time t = 0 and t = 72 hours are given in Figures 4 and 5 respectively. Model 
parameters that were fitted were: k1 = 0.0476, g = 0.1129, k2 = 0.3193 and b = 0.9296. The fixed parameters were 
dispersion D = 0.0001; death rates µa, = µs = µG, = µM = O; starting distribution parameters ao = 100, Bo= 0.05; 
mesh size Lit= 0.5, Llx = 0.05,tmax = 100, Xmax = 5. For parameter descriptions and units see Table 1. 
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Fig. 4. Model (a) and experimental (b) steady DNA distribution (SDD) for human cell line NZM6 at time t = 0. 
Parameter values given in Figure 3. The shaded peaks in the left hand side of (b) indicate the internal standard for the 
flow cytometry. 
%G2M = 10.54. The doubling time for this cell line is approximately Td = 29 hours. 
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Fig. 5. Model (a) and experimental (b) DNA distribution (SDD) for human cell line NZM6 at time t = 72 hours. The 
steady DNA distribution (SDD) was reached (see Figure 4) then division stopped (b = 0) at time t = 0 hours. It can be 
seen that cells have accumulated in the G2M-phase region. Parameter values given in Figure 3. The shaded peaks in 
the left hand side of (b) indicate the internal standard for the flow cytometry. 
Thus, substituting values of Ta1 , Ts, Ta2M, and Tc from equations (17)-(20) into equations 
(21)-(24), and using the estimate of TM= 0.5 hours ([3]), we gain parameter estimates 
for the NZM6 cell line of; kt = 0.0624,g = 0.1139, k2 = 0.8462 and b = 2. The SDD 
associated with this parameter set was obtained by using the numerical method of finite 
differences to evaluate the model equations (1), (3) and (4). Simpsons's rule was used to 
estimate the integral in equation (11) for S-phase cells, with the substitution y for y. 
To determine the existence of an SDD in the model, we measured the percentage of 
cells in G1 -phase at each time step and compared this to the percentage of cells in Gt -
phase 5 hours previously. When the squared difference between these two values was 
less than 0.1 %, we concluded that a SDD had been reached. To mimic the addition of 
paclitaxel and the simultaneous inhibition of cell division we set the division rate b to 
zero at time t = 0 hours and ran the model for 72 hours. We calculated the percentage of 
cells in each phase as a function of time and compared this to the experimental data. We 
minimised the sum of squared errors in order to obtain model outputs as close as possible 
to the data. The sum of squared errors function is given by: 
(26) 
where Pi(tj) is the percentage of cells in phase number i at time tj as predicted by the 
model and 'Yi(tj) is the corresponding data point. There are Y' = 3 phases found experi-
mentally (being Gt, Sand G2M-phase) and/ data points. 
In this classic discrete inverse problem we wish to find a parameter estimation that 
minimises the sum of squared errors ([4]). The minimisation algorithm was supplied by 
the MATLAB functionfinincon. This function uses a sequential programming method to 
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perform the optimisation procedure. The parameters we chose to fit were k1, g, kz and b. 
All other model parameters were fixed at the values specified in Figure 3. We imposed 
the constraints k1 E (0, 1], g E (0.05,2], kz E (0, 1] and b E (O,oo]. These constraints en-
sure positivity of the parameter values, reflect the fact that k1 and kz are probabilities and 
assume that the time spent in S-phase is approximately between 30 minutes and 20 hours. 
Figures 3, 4 and 5 indicate that the model describes accurate cell kinetics for melanoma 
cell line NZM6. It can be seen in Figure 3 that after the addition of paclitaxel, the per-
centage of cells in G1-phase decline while those in G2M-phase correspondingly increase. 
The percentage of cells in S phase decline after an initial time delay. We did not include 
the SDD data in our parameter fitting procedure but we see from comparisons with SDD 
data obtained experimentally (Figures 4 and 5) that our model gives similar DNA distri-
butions. We found that the values k1 = 0.0476, g = 0.1129, kz = 0.3193 and b = 0.9296 
produce the least square error (117.85) between model and data as given by equation 
(26). The optimisation procedure was greatly assisted by first optimising with D = 0 and 
then taking the result when D cf. 0. Such an optimisation procedure cannot be guaranteed 
of finding a global minimum of our objective function, equation (26). A sensitivity anal-
ysis of the value of this objective function to changes in parameter values indicates that 
our parameter estimation is unique in the feasible region of parameter space. It is also 
evident (Figure 6) that the objective function is not sensitive to changes in the division 
rate parameter close to the optimal value of b = 0.9296. 
4. Discussion 
The model that we have developed represents an approach to the human tumour cell cycle 
that we consider has the potential to complement and extend previous models. We have 
modelled different phases of the cell cycle ([30,25,28]) and have validated the model 
using flow cytometry ([26, 19,6,33]). We have also used results from an age modelling 
approach ([29,33]) to gain initial estimates of model parameters for a cell line with a 
steady DNA distribution. Our methodology differs from other models in that our mea-
sure of cell size ([5,27,8,9,31]) is cellular DNA content, we have included transition 
probabilities between phases and we have a dispersion term to allow for experimental 
variability in measurement of the DNA content so that we can directly compare model 
outputs with DNA profiles. 
The transition probability terms linking G1- to S-phase and G2- to M-phase reflect the 
known variability in the length of the cell cycle. In contrast to this variability, the length 
of S-phase, which is accompanied by the progressive replication of DNA, is approxi-
mately constant and is of the order of 12 hours in human cancer cells. However, its length 
does vary among different human cancers ([37]) and it might therefore be expected to 
vary within a population. A dispersion term has therefore been provided to reflect this 
behaviour. The passage through M-phase, although it is considerably shorter than that 
for S-phase, similarly takes a finite time. An analogous term to that used for S-phase can 
be incorporated into the model to reflect this behaviour. This has been omitted from the 
current model because it plays only a very small role in modelling the behaviour of the 
NZM6 cell line. 
We have shown that setting b, the division rate parameter for the NZM6 cell line, 
to zero was sufficient to model experimental results when paclitaxel was added to the 
cell population with steady DNA distribution. The success of the model in predicting 
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Fig. 6. The objective function (sum of squared errors), equation 26, as a function of the division rate, b, and k2, the 
transition from G2 to M-phase. The minimum occurs at b = 0.9296 and k2 = 0.3193 but the objective function value 
is not sensitive to larger values of b if k2 = 0.3193 is fixed. This can be seen in the plot as a valley that also bends in 
the k2 direction with b = 0.5. Other model parameter values are given in Figure 3. 
the behaviour of these cells at different times after exposure to paclitaxel emphasises the 
value of the existing incorporated terms used to model the cycle phase transitions, and 
provides the background for extension to other human tumour cell lines. The nature of 
the terms in this model that link Gr- to S-phase and G2- to M-phase will facilitate our 
understanding of the cell cycle, where all-or-nothing transitions are provided by positive 
feedback controls on the respective cdk2 and cdkl enzyme complexes [18]. 
4.1. Extension of the model to incorporate cell death, senescence and cycle arrest 
Most human tumour cell lines growing in vitro under normal culture conditions have a 
low spontaneous death rate. However, exposure to agents such as radiation or chemother-
apy can induce cell death, which generally occurs by apoptosis. Paclitaxel, used here to 
cause arrest of cell division, is thought to exert its anticancer effects by the induction of 
apoptosis subsequent to mitotic arrest ([24]). Apoptosis is accompanied by the progres-
sive loss of cellular DNA, resulting in pe1turbation of the DNA flow cytometry profile. 
Our model can easily be extended to incorporate dying cells whose DNA content reduces 
progressively with time. This will facilitate the analysis of drug-treated populations where 
a proportion of cells is undergoing cell death and will also allow the description of the 
growth of human tumours in vivo. The model will include sub-population R(x, t) for this 
:·'!·· 
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removal phase, given by: 
dR d2R d(gRR) 
Tt(x,t) = DR dx2 (x,t) + dx (x,t) 
+(µGp1+µsS+µG 2G2+µMM), O<x<oo, t>O, (27) 
with side conditions 
R(x,0)=0, O<x<oo, DRR(O,t)-gR(O,t)=O, t2:'.0. (28) 
Equation (27) is virtually identical to equation (2), except cell DNA content is decreasing 
at an average rate gR per unit time and the dispersion coefficient here is DR. The source 
term in this equation is the sum of the loss (due to cell death) terms in equations (1)-(4). 
Cell cultures treated with anticancer drugs or radiation may be induced to enter a 
senescent state during G1 phase. Again, the model can be modified to account for such 
behaviour by including a sub-population, Go that will accumulate with time and can be 
written as 
dGo Tt(x,t) = -µG0Go(x,t) +kG0G1(x,t), 0 < x < oo, t > 0, (29) 
with side conditions 
Go(x,O) = 0, 0 < x < oo, (30) 
where the term kGo G1 accounts for the transition rate into this senescent phase from 
the G1 -phase and µGo is the death rate in this phase. The term µGo Go would join the 
source terms in the removal phase (equation (27)). The G1-phase equation is accordingly 
modified to 
(31) 
with the other equations unmodified as per equations (2), (3) and (4). 
A further response of cancer cells exposed to radiation or anticancer drugs is the in-
duction of transient, reversible cell cycle arrest. Cycle arrest occurs most commonly by 
a change in rates of transition from G1-phase to S-phase, and from G2-phase and M-
phase. These changes can be readily modelled by incorporating transient decreases in the 
corresponding equations for cell cycle transition. 
The analysis of DNA profiles of cells obtained directly from human tumours are com-
plex because of the presence of both tumour and normal cells. Moreover, two or more 
tumour cell populations with differing DNA content may be present, giving rise to multi-
ple superimposed steady DNA distributions. Human cancer is also characterised by a high 
deatl'i. rate ([36]) and by transitions of cells into a terminal non-growing or senescent state. 
Our model has the potential to model superimposed populations and to include terms for 
apoptosis, senescence and transient cell cycle arrest. These can be used to predict the 
effects of radiation and anticancer drugs, which are used for the treatment of human can-
cer. The profiles generated can be compared to experimental data from short-term culture 
of patients tumour material obtained at surgery. The ultimate aim of our approach is to 
provide insights as to why some patients fail to respond to treatment and to help in the 
development of strategies to overcome the resistance of their cancers to therapy. 
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A. Appendix 
The part of the integral in (7) corresponding to the image of yin the boundary, namely 
h when lo(x, t) = 0, x :S: C, where C is a positive real number, can be written as 
lz(x,t;-r) = l"' Io(y,t)y(-r,x,y)(l+v(-r,x,y))e-x(y+gi-)/W,dy. 
In this integral, when use is made of the positivity of both Io and the exponential function, 
together with the mean value theorem for integrals,.it is seen that 
h = (1 + v( -r,x, ~))e-x(l;+gi-)/Wi-1°" Io(y, t)y( -r,x,y) dy, 
:S: (1 + v( -r,x, ~) )e-x(l;+gi-)/wi-7, 
where~ E (C, oo ). It follows from this with C ~ 1, x ~ 1, -r :s; 20 and Das given in Table 1 
that 
[z :S: 2e-x(R+gi-)/wq 
Hence it follows for the parameter values used for this paper, [z can be neglected with 
respect to I and the use of the approximate Green's function, y, as is used in the numerical 
calculations has been justified. 
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Table 1. Model parameters and variables 
Parameter Description Dimensions Value 
x relative DNA content [1] 
t time hours 
Ts time in S-phase hours l g 
G1 (x,t) number density of cells in Gt -phase 
S(x,t) number density of cells in S-phase 
G2(x,t) number density of cells in Gz-phase 
M(x,t) number density of cells in M-phase 
D dispersion coefficient f 0.0001 g average growth rate of DNA in S-phase 
ki transition probability of cells from G1 to S-phase I m 
k2 transition probability of cells from G2 to M-phase l m 
b division rate l [tJ 
llci variance of starting distribution 0.05 
ao height of starting distribution 100 
µa, death rate in G1 -phase l m 
µs death rate in S-phase l m 
µa2 death rate in Gi-phase l m 
µM death rate in M-phase I [tJ 
